Anavex Life Sciences Corp (AVXL)

[frrol]

Our poster has been removed. On the one hand, oral communications are more important than posters. On the other, our poster was for "SIGMAR1 gene variant analysis", which was an important and still undisclosed endpoint and the last big question mark from our 2b/3. The communication title doesn't mention it, so we're now in the dark on whether we'll be getting it at CTAD. Who knows. Is the paper about to be published in the next few weeks, requiring the poster withdrawal? Will the variant analysis be included in the talk anyway? Let's see what CTAD brings. Btw the company should be announcing our CTAD attendance pretty soon.